Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

Europe Lipid Regulating Drugs Market Report to 2021

  • QYR777556
  • 103 Pages
  • November 2016
  • Pharmaceuticals
Download Sample    Get Discount   
 
Notes:

Sales, means the sales volume of Lipid Regulating Drugs

Revenue, means the sales value of Lipid Regulating Drugs

This report studies sales (consumption) of Lipid Regulating Drugs in Europe market, especially in Germany, UK, France, Italy, Spain and Russia, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions, covering

Novartis

Pfizer, Inc.

Roche

Sanofi

Merck & Co., Inc.

GlaxoSmithKline plc

Johnson & Johnson

AstraZeneca plc.

Eli Lilly and Company

Abbvie

AMGen

Teva Pharmaceutical Industries Ltd.

Bayer AG

Bristol-Myers Squibb

Astellas Pharma

Daiichi Sankyo

Abbott Laboratories

Yangtze River Pharmaceutical Group

BAX

Market Segment by Regions, this report splits Europe into several key Regions, with sales (consumption), revenue, market share and growth rate of Lipid Regulating Drugs in these regions, from 2011 to 2021 (forecast), like

Germany

France

UK

Italy

Spain

Russia

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

Hydroxymethylglutaryl Coenzyme A Reductase Inhibitor

Phenoxyacetic Acid

Nicotinic Acid

Others

Split by applications, this report focuses on sales, market share and growth rate of Lipid Regulating Drugs in each application, can be divided into

First Level Hospital

Two Level Hospital

Three Level Hospital

Others

Table of Contents

1 Lipid Regulating Drugs Overview

1.1 Product Overview and Scope of Lipid Regulating Drugs

1.2 Classification of Lipid Regulating Drugs

1.2.1 Hydroxymethylglutaryl Coenzyme A Reductase Inhibitor

1.2.2 Phenoxyacetic Acid

1.2.3 Nicotinic Acid

1.2.4 Others

1.3 Applications of Lipid Regulating Drugs

1.3.1 First Level Hospital

1.3.2 Two Level Hospital

1.3.3 Three Level Hospital

1.3.4 Others

1.4 Lipid Regulating Drugs Market by Regions

1.4.1 Germany Status and Prospect (2011-2021)

1.4.2 France Status and Prospect (2011-2021)

1.4.3 UK Status and Prospect (2011-2021)

1.4.4 Italy Status and Prospect (2011-2021)

1.4.5 Spain Status and Prospect (2011-2021)

1.4.6 Russia Status and Prospect (2011-2021)

1.5 Europe Market Size (Value and Volume) of Lipid Regulating Drugs (2011-2021)

1.5.1 Europe Lipid Regulating Drugs Sales, Revenue and Price (2011-2021)

1.5.2 Europe Lipid Regulating Drugs Sales and Growth Rate (2011-2021)

1.5.3 Europe Lipid Regulating Drugs Revenue and Growth Rate (2011-2021)

2 Europe Lipid Regulating Drugs by Manufacturers, Type and Application

2.1 Europe Lipid Regulating Drugs Market Competition by Manufacturers

2.1.1 Europe Lipid Regulating Drugs Sales and Market Share of Key Manufacturers (2015 and 2016)

2.1.2 Europe Lipid Regulating Drugs Revenue and Share by Manufacturers (2015 and 2016)

2.2 Europe Lipid Regulating Drugs (Volume and Value) by Type

2.2.1 Europe Lipid Regulating Drugs Sales and Market Share by Type (2011-2021)

2.2.2 Europe Lipid Regulating Drugs Revenue and Market Share by Type (2011-2021)

2.3 Europe Lipid Regulating Drugs (Volume and Value) by Regions

2.3.1 Europe Lipid Regulating Drugs Sales and Market Share by Regions (2011-2021)

2.3.2 Europe Lipid Regulating Drugs Revenue and Market Share by Regions (2011-2021)

2.4 Europe Lipid Regulating Drugs (Volume) by Application

3 Germany Lipid Regulating Drugs (Volume, Value and Sales Price)

3.1 Germany Lipid Regulating Drugs Sales and Value (2011-2021)

3.1.1 Germany Lipid Regulating Drugs Sales and Growth Rate (2011-2021)

3.1.2 Germany Lipid Regulating Drugs Revenue and Growth Rate (2011-2021)

3.1.3 Germany Lipid Regulating Drugs Sales Price Trend (2011-2021)

3.2 Germany Lipid Regulating Drugs Sales and Market Share by Manufacturers

3.3 Germany Lipid Regulating Drugs Sales and Market Share by Type

3.4 Germany Lipid Regulating Drugs Sales and Market Share by Applications

4 UK Lipid Regulating Drugs (Volume, Value and Sales Price)

4.1 UK Lipid Regulating Drugs Sales and Value (2011-2021)

4.1.1 UK Lipid Regulating Drugs Sales and Growth Rate (2011-2021)

4.1.2 UK Lipid Regulating Drugs Revenue and Growth Rate (2011-2021)

4.1.3 UK Lipid Regulating Drugs Sales Price Trend (2011-2021)

4.2 UK Lipid Regulating Drugs Sales and Market Share by Manufacturers

4.3 UK Lipid Regulating Drugs Sales and Market Share by Type

4.4 UK Lipid Regulating Drugs Sales and Market Share by Applications

5 France Lipid Regulating Drugs (Volume, Value and Sales Price)

5.1 France Lipid Regulating Drugs Sales and Value (2011-2021)

5.1.1 France Lipid Regulating Drugs Sales and Growth Rate (2011-2021)

5.1.2 France Lipid Regulating Drugs Revenue and Growth Rate (2011-2021)

5.1.3 France Lipid Regulating Drugs Sales Price Trend (2011-2021)

5.2 France Lipid Regulating Drugs Sales and Market Share by Manufacturers

5.3 France Lipid Regulating Drugs Sales and Market Share by Type

5.4 France Lipid Regulating Drugs Sales and Market Share by Applications

6 Italy Lipid Regulating Drugs (Volume, Value and Sales Price)

6.1 Italy Lipid Regulating Drugs Sales and Value (2011-2021)

6.1.1 Italy Lipid Regulating Drugs Sales and Growth Rate (2011-2021)

6.1.2 Italy Lipid Regulating Drugs Revenue and Growth Rate (2011-2021)

6.1.3 Italy Lipid Regulating Drugs Sales Price Trend (2011-2021)

6.2 Italy Lipid Regulating Drugs Sales and Market Share by Manufacturers

6.3 Italy Lipid Regulating Drugs Sales and Market Share by Type

6.4 Italy Lipid Regulating Drugs Sales and Market Share by Applications

7 Russia Lipid Regulating Drugs (Volume, Value and Sales Price)

7.1 Russia Lipid Regulating Drugs Sales and Value (2011-2021)

7.1.1 Russia Lipid Regulating Drugs Sales and Growth Rate (2011-2021)

7.1.2 Russia Lipid Regulating Drugs Revenue and Growth Rate (2011-2021)

7.1.3 Russia Lipid Regulating Drugs Sales Price Trend (2011-2021)

7.2 Russia Lipid Regulating Drugs Sales and Market Share by Manufacturers

7.3 Russia Lipid Regulating Drugs Sales and Market Share by Type

7.4 Russia Lipid Regulating Drugs Sales and Market Share by Applications

8 Spain Lipid Regulating Drugs (Volume, Value and Sales Price)

8.1 Spain Lipid Regulating Drugs Sales and Value (2011-2021)

8.1.1 Spain Lipid Regulating Drugs Sales and Growth Rate (2011-2021)

8.1.2 Spain Lipid Regulating Drugs Revenue and Growth Rate (2011-2021)

8.1.3 Spain Lipid Regulating Drugs Sales Price Trend (2011-2021)

8.2 Spain Lipid Regulating Drugs Sales and Market Share by Manufacturers

8.3 Spain Lipid Regulating Drugs Sales and Market Share by Type

8.4 Spain Lipid Regulating Drugs Sales and Market Share by Applications

9 Europe Lipid Regulating Drugs Manufacturers Analysis

9.1 Novartis

9.1.1 Company Basic Information,Manufacturing Base and Competitors

9.1.2 Lipid Regulating Drugs Product Type and Technology

9.1.2.1 Type I

9.1.2.2 Type II

9.1.3 Lipid Regulating Drugs Sales, Revenue, Price of Novartis (2015 and 2016)

9.2 Pfizer, Inc.

9.2.1 Company Basic Information,Manufacturing Base and Competitors

9.2.2 Lipid Regulating Drugs Product Type and Technology

9.2.2.1 Type I

9.2.2.2 Type II

9.2.3 Lipid Regulating Drugs Sales, Revenue, Price of Pfizer, Inc. (2015 and 2016)

9.3 Roche

9.3.1 Company Basic Information,Manufacturing Base and Competitors

9.3.2 Lipid Regulating Drugs Product Type and Technology

9.3.2.1 Type I

9.3.2.2 Type II

9.3.3 Lipid Regulating Drugs Sales, Revenue, Price of Roche (2015 and 2016)

9.4 Sanofi

9.4.1 Company Basic Information,Manufacturing Base and Competitors

9.4.2 Lipid Regulating Drugs Product Type and Technology

9.4.2.1 Type I

9.4.2.2 Type II

9.4.3 Lipid Regulating Drugs Sales, Revenue, Price of Sanofi (2015 and 2016)

9.5 Merck & Co., Inc.

9.5.1 Company Basic Information,Manufacturing Base and Competitors

9.5.2 Lipid Regulating Drugs Product Type and Technology

9.5.2.1 Type I

9.5.2.2 Type II

9.5.3 Lipid Regulating Drugs Sales, Revenue, Price of Merck & Co., Inc. (2015 and 2016)

9.6 GlaxoSmithKline plc

9.6.1 Company Basic Information,Manufacturing Base and Competitors

9.6.2 Lipid Regulating Drugs Product Type and Technology

9.6.2.1 Type I

9.6.2.2 Type II

9.6.3 Lipid Regulating Drugs Sales, Revenue, Price of GlaxoSmithKline plc (2015 and 2016)

9.7 Johnson & Johnson

9.7.1 Company Basic Information,Manufacturing Base and Competitors

9.7.2 Lipid Regulating Drugs Product Type and Technology

9.7.2.1 Type I

9.7.2.2 Type II

9.7.3 Lipid Regulating Drugs Sales, Revenue, Price of Johnson & Johnson (2015 and 2016)

9.8 AstraZeneca plc.

9.8.1 Company Basic Information,Manufacturing Base and Competitors

9.8.2 Lipid Regulating Drugs Product Type and Technology

9.8.2.1 Type I

9.8.2.2 Type II

9.8.3 Lipid Regulating Drugs Sales, Revenue, Price of AstraZeneca plc. (2015 and 2016)

9.9 Eli Lilly and Company

9.9.1 Company Basic Information,Manufacturing Base and Competitors

9.9.2 Lipid Regulating Drugs Product Type and Technology

9.9.2.1 Type I

9.9.2.2 Type II

9.9.3 Lipid Regulating Drugs Sales, Revenue, Price of Eli Lilly and Company (2015 and 2016)

9.10 Abbvie

9.10.1 Company Basic Information,Manufacturing Base and Competitors

9.10.2 Lipid Regulating Drugs Product Type and Technology

9.10.2.1 Type I

9.10.2.2 Type II

9.10.3 Lipid Regulating Drugs Sales, Revenue, Price of Abbvie (2015 and 2016)

9.11 AMGen

9.11.1 Company Basic Information,Manufacturing Base and Competitors

9.11.2 Lipid Regulating Drugs Product Type and Technology

9.11.2.1 Type I

9.11.2.2 Type II

9.11.3 Lipid Regulating Drugs Sales, Revenue, Price of AMGen (2015 and 2016)

9.12 Teva Pharmaceutical Industries Ltd.

9.12.1 Company Basic Information,Manufacturing Base and Competitors

9.12.2 Lipid Regulating Drugs Product Type and Technology

9.12.2.1 Type I

9.12.2.2 Type II

9.12.3 Lipid Regulating Drugs Sales, Revenue, Price of Teva Pharmaceutical Industries Ltd. (2015 and 2016)

9.13 Bayer AG

9.13.1 Company Basic Information,Manufacturing Base and Competitors

9.13.2 Lipid Regulating Drugs Product Type and Technology

9.13.2.1 Type I

9.13.2.2 Type II

9.13.3 Lipid Regulating Drugs Sales, Revenue, Price of Bayer AG (2015 and 2016)

9.14 Bristol-Myers Squibb

9.14.1 Company Basic Information,Manufacturing Base and Competitors

9.14.2 Lipid Regulating Drugs Product Type and Technology

9.14.2.1 Type I

9.14.2.2 Type II

9.14.3 Lipid Regulating Drugs Sales, Revenue, Price of Bristol-Myers Squibb (2015 and 2016)

9.15 Astellas Pharma

9.15.1 Company Basic Information,Manufacturing Base and Competitors

9.15.2 Lipid Regulating Drugs Product Type and Technology

9.15.2.1 Type I

9.15.2.2 Type II

9.15.3 Lipid Regulating Drugs Sales, Revenue, Price of Astellas Pharma (2015 and 2016)

9.16 Daiichi Sankyo

9.16.1 Company Basic Information,Manufacturing Base and Competitors

9.16.2 Lipid Regulating Drugs Product Type and Technology

9.16.2.1 Type I

9.16.2.2 Type II

9.16.3 Lipid Regulating Drugs Sales, Revenue, Price of Daiichi Sankyo (2015 and 2016)

9.17 Abbott Laboratories

9.17.1 Company Basic Information,Manufacturing Base and Competitors

9.17.2 Lipid Regulating Drugs Product Type and Technology

9.17.2.1 Type I

9.17.2.2 Type II

9.17.3 Lipid Regulating Drugs Sales, Revenue, Price of Abbott Laboratories (2015 and 2016)

9.18 Yangtze River Pharmaceutical Group

9.18.1 Company Basic Information,Manufacturing Base and Competitors

9.18.2 Lipid Regulating Drugs Product Type and Technology

9.18.2.1 Type I

9.18.2.2 Type II

9.18.3 Lipid Regulating Drugs Sales, Revenue, Price of Yangtze River Pharmaceutical Group (2015 and 2016)

9.19 BAX

9.19.1 Company Basic Information,Manufacturing Base and Competitors

9.19.2 Lipid Regulating Drugs Product Type and Technology

9.19.2.1 Type I

9.19.2.2 Type II

9.19.3 Lipid Regulating Drugs Sales, Revenue, Price of BAX (2015 and 2016)

10 Lipid Regulating Drugs Technology and Development Trend

10.1 Lipid Regulating Drugs Technology Analysis

10.2 Lipid Regulating Drugs Technology Development Trend

11 Research Findings and Conclusion

List of Tables and Figures

Figure Picture of Lipid Regulating Drugs

Table Classification of Lipid Regulating Drugs

Figure Europe Sales Market Share of Lipid Regulating Drugs by Types in 2015

Figure Hydroxymethylglutaryl Coenzyme A Reductase Inhibitor Picture

Figure Phenoxyacetic Acid Picture

Figure Nicotinic Acid Picture

Figure Others Picture

Table Applications of Lipid Regulating Drugs

Figure Europe Sales Market Share of Lipid Regulating Drugs by Applications in 2015

Figure First Level Hospital Examples

Figure Two Level Hospital Examples

Figure Three Level Hospital Examples

Figure Others Examples

Figure Germany Lipid Regulating Drugs Revenue and Growth Rate (2011-2021)

Figure France Lipid Regulating Drugs Revenue and Growth Rate (2011-2021)

Figure UK Lipid Regulating Drugs Revenue and Growth Rate (2011-2021)

Figure Italy Lipid Regulating Drugs Revenue and Growth Rate (2011-2021)

Figure Spain Lipid Regulating Drugs Revenue and Growth Rate (2011-2021)

Figure Russia Lipid Regulating Drugs Revenue and Growth Rate (2011-2021)

Table Europe Lipid Regulating Drugs Sales, Revenue and Price (2011-2021)

Figure Europe Lipid Regulating Drugs Sales and Growth Rate (2011-2021)

Figure Europe Lipid Regulating Drugs Revenue and Growth Rate (2011-2021)

Table Europe Lipid Regulating Drugs Sales of Key Manufacturers (2015 and 2016)

Table Europe Lipid Regulating Drugs Sales Share by Manufacturers (2015 and 2016)

Figure 2015 Lipid Regulating Drugs Sales Share by Manufacturers

Figure 2016 Lipid Regulating Drugs Sales Share by Manufacturers

Table Europe Lipid Regulating Drugs Revenue by Manufacturers (2015 and 2016)

Table Europe Lipid Regulating Drugs Revenue Share by Manufacturers (2015 and 2016)

Table 2015 Europe Lipid Regulating Drugs Revenue Share by Manufacturers

Table 2016 Europe Lipid Regulating Drugs Revenue Share by Manufacturers

Table Europe Lipid Regulating Drugs Sales and Market Share by Type (2011-2021)

Table Europe Lipid Regulating Drugs Sales Share by Type (2011-2021)

Figure Sales Market Share of Lipid Regulating Drugs by Type (2011-2021)

Figure Europe Lipid Regulating Drugs Sales Growth Rate by Type (2011-2021)

Table Europe Lipid Regulating Drugs Revenue and Market Share by Type (2011-2021)

Table Europe Lipid Regulating Drugs Revenue Share by Type (2011-2021)

Figure Revenue Market Share of Lipid Regulating Drugs by Type (2011-2021)

Figure Europe Lipid Regulating Drugs Revenue Growth Rate by Type (2011-2021)

Table Europe Lipid Regulating Drugs Sales and Market Share by Regions (2011-2021)

Table Europe Lipid Regulating Drugs Sales Share by Regions (2011-2021)

Figure Sales Market Share of Lipid Regulating Drugs by Regions (2011-2021)

Figure Europe Lipid Regulating Drugs Sales Growth Rate by Regions (2011-2021)

Table Europe Lipid Regulating Drugs Revenue and Market Share by Regions (2011-2021)

Table Europe Lipid Regulating Drugs Revenue Share by Regions (2011-2021)

Figure Revenue Market Share of Lipid Regulating Drugs by Regions (2011-2021)

Figure Europe Lipid Regulating Drugs Revenue Growth Rate by Regions (2011-2021)

Table Europe Lipid Regulating Drugs Sales and Market Share by Application (2011-2021)

Table Europe Lipid Regulating Drugs Sales Share by Application (2011-2021)

Figure Sales Market Share of Lipid Regulating Drugs by Application (2011-2021)

Figure Europe Lipid Regulating Drugs Sales Growth Rate by Application (2011-2021)

Figure Germany Lipid Regulating Drugs Sales and Growth Rate (2011-2021)

Figure Germany Lipid Regulating Drugs Revenue and Growth Rate (2011-2021)

Figure Germany Lipid Regulating Drugs Sales Price Trend (2011-2021)

Table Germany Lipid Regulating Drugs Sales by Manufacturers (2015 and 2016)

Table Germany Lipid Regulating Drugs Market Share by Manufacturers (2015 and 2016)

Table Germany Lipid Regulating Drugs Sales by Type (2015 and 2016)

Table Germany Lipid Regulating Drugs Market Share by Type (2015 and 2016)

Table Germany Lipid Regulating Drugs Sales by Applications (2015 and 2016)

Table Germany Lipid Regulating Drugs Market Share by Applications (2015 and 2016)

Figure UK Lipid Regulating Drugs Sales and Growth Rate (2011-2021)

Figure UK Lipid Regulating Drugs Revenue and Growth Rate (2011-2021)

Figure UK Lipid Regulating Drugs Sales Price Trend (2011-2021)

Table UK Lipid Regulating Drugs Sales by Manufacturers (2015 and 2016)

Table UK Lipid Regulating Drugs Market Share by Manufacturers (2015 and 2016)

Table UK Lipid Regulating Drugs Sales by Type (2015 and 2016)

Table UK Lipid Regulating Drugs Market Share by Type (2015 and 2016)

Table UK Lipid Regulating Drugs Sales by Applications (2015 and 2016)

Table UK Lipid Regulating Drugs Market Share by Applications (2015 and 2016)

Figure France Lipid Regulating Drugs Sales and Growth Rate (2011-2021)

Figure France Lipid Regulating Drugs Revenue and Growth Rate (2011-2021)

Figure France Lipid Regulating Drugs Sales Price Trend (2011-2021)

Table France Lipid Regulating Drugs Sales by Manufacturers (2015 and 2016)

Table France Lipid Regulating Drugs Market Share by Manufacturers (2015 and 2016)

Table France Lipid Regulating Drugs Sales by Type (2015 and 2016)

Table France Lipid Regulating Drugs Market Share by Type (2015 and 2016)

Table France Lipid Regulating Drugs Sales by Applications (2015 and 2016)

Table France Lipid Regulating Drugs Market Share by Applications (2015 and 2016)

Figure Italy Lipid Regulating Drugs Sales and Growth Rate (2011-2021)

Figure Italy Lipid Regulating Drugs Revenue and Growth Rate (2011-2021)

Figure Italy Lipid Regulating Drugs Sales Price Trend (2011-2021)

Table Italy Lipid Regulating Drugs Sales by Manufacturers (2015 and 2016)

Table Italy Lipid Regulating Drugs Market Share by Manufacturers (2015 and 2016)

Table Italy Lipid Regulating Drugs Sales by Type (2015 and 2016)

Table Italy Lipid Regulating Drugs Market Share by Type (2015 and 2016)

Table Italy Lipid Regulating Drugs Sales by Applications (2015 and 2016)

Table Italy Lipid Regulating Drugs Market Share by Applications (2015 and 2016)

Figure Russia Lipid Regulating Drugs Sales and Growth Rate (2011-2021)

Figure Russia Lipid Regulating Drugs Revenue and Growth Rate (2011-2021)

Figure Russia Lipid Regulating Drugs Sales Price Trend (2011-2021)

Table Russia Lipid Regulating Drugs Sales by Manufacturers (2015 and 2016)

Table Russia Lipid Regulating Drugs Market Share by Manufacturers (2015 and 2016)

Table Russia Lipid Regulating Drugs Sales by Type (2015 and 2016)

Table Russia Lipid Regulating Drugs Market Share by Type (2015 and 2016)

Table Russia Lipid Regulating Drugs Sales by Applications (2015 and 2016)

Table Russia Lipid Regulating Drugs Market Share by Applications (2015 and 2016)

Figure Spain Lipid Regulating Drugs Sales and Growth Rate (2011-2021)

Figure Spain Lipid Regulating Drugs Revenue and Growth Rate (2011-2021)

Figure Spain Lipid Regulating Drugs Sales Price Trend (2011-2021)

Table Spain Lipid Regulating Drugs Sales by Manufacturers (2015 and 2016)

Table Spain Lipid Regulating Drugs Market Share by Manufacturers (2015 and 2016)

Table Spain Lipid Regulating Drugs Sales by Type (2015 and 2016)

Table Spain Lipid Regulating Drugs Market Share by Type (2015 and 2016)

Table Spain Lipid Regulating Drugs Sales by Applications (2015 and 2016)

Table Spain Lipid Regulating Drugs Market Share by Applications (2015 and 2016)

Table Novartis Basic Information List

Table Lipid Regulating Drugs Sales, Revenue, Price of Novartis (2015 and 2016)

Table Pfizer, Inc. Basic Information List

Table Lipid Regulating Drugs Sales, Revenue, Price of Pfizer, Inc. (2015 and 2016)

Table Roche Basic Information List

Table Lipid Regulating Drugs Sales, Revenue, Price of Roche (2015 and 2016)

Table Sanofi Basic Information List

Table Lipid Regulating Drugs Sales, Revenue, Price of Sanofi (2015 and 2016)

Table Merck & Co., Inc. Basic Information List

Table Lipid Regulating Drugs Sales, Revenue, Price of Merck & Co., Inc. (2015 and 2016)

Table GlaxoSmithKline plc Basic Information List

Table Lipid Regulating Drugs Sales, Revenue, Price of GlaxoSmithKline plc (2015 and 2016)

Table Johnson & Johnson Basic Information List

Table Lipid Regulating Drugs Sales, Revenue, Price of Johnson & Johnson (2015 and 2016)

Table AstraZeneca plc. Basic Information List

Table Lipid Regulating Drugs Sales, Revenue, Price of AstraZeneca plc. (2015 and 2016)

Table Eli Lilly and Company Basic Information List

Table Lipid Regulating Drugs Sales, Revenue, Price of Eli Lilly and Company (2015 and 2016)

Table Abbvie Basic Information List

Table Lipid Regulating Drugs Sales, Revenue, Price of Abbvie (2015 and 2016)

...

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Similar Reports

Protein Therapeutics Market by Product (Monoclonal Antibodies, Insulin, Fusion Protein, Erythropoietin, Interferon, Human Growth Hormone, and Follicle Stimulating Hormone) and Application (Metabolic Disorders, Immunologic Disorders, Hematological Disorders, Cancer, Hormonal Disorders, Genetic Disorders, and Others) - Global Opportunity Analysis and Industry Forecast, 2017-2023

Proteins that are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases are known as protein therapeutics. The global protein therapeutics market accounted for $140,109 million in 2016, and is anticipated to rea...

  • Publish Date: November 14, 2017
  • $5370
Global Cord Blood Banking Services (Stem Cell) Market, Size, Share, Trends, Forecast, Global Analysis, Research, Report, Segmentation, and Future Demand, 2012 - 2020

Umbilical cord blood bank is storage facility that collects cord blood after the childbirth from placenta. Cord blood is rich source of stem cell used in treatment of different chronic diseases. Private and public cord blood banks are the two major types of banks that are prevalent in th...

  • Publish Date: July 20, 2017
  • $5370